Jupiter Neurosciences, Inc. (JUNS) vs 60 Degrees Pharmaceuticals Inc. (SXTP)

Jupiter Neurosciences, Inc. and 60 Degrees Pharmaceuticals Inc. are both Biotechnology companies. Jupiter Neurosciences, Inc. and 60 Degrees Pharmaceuticals Inc. are of similar size ($4.1M and $3.8M). Jupiter Neurosciences, Inc. has the higher net margin (0.00% vs −650.3%) and the higher return on invested capital (0.00% vs −348.6%). Across the 11 metrics below, 60 Degrees Pharmaceuticals Inc. leads on 7 and Jupiter Neurosciences, Inc. on 4.

Valuation

Metric JUNS SXTP Biotechnology median
P/E n/m n/m 7.88
P/S n/m 2.56 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 1.84 10.73
Earnings yield (716.02%) (185.50%) (28.84%)
Free cash flow yield (486.93%) (291.87%) (23.03%)

Profitability

Metric JUNS SXTP Biotechnology median
Gross margin — 43.42% 65.16%
Operating margin 0.00% (691.33%) 0.00%
Net margin 0.00% (650.34%) 0.00%
Free cash flow margin 0.00% (745.93%) 0.00%
Return on equity (1,888.80%) 110.82% (57.72%)
Return on assets (239.36%) (186.70%) (49.22%)
Return on invested capital 0.00% (348.64%) 0.00%

Growth

Metric JUNS SXTP Biotechnology median
Revenue growth (TTM) — 23.41% 5.64%
EPS growth (last fiscal year) (212.50%) 84.19% —
Revenue growth, 5-year CAGR — (11.18%) 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric JUNS SXTP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.66 2.32 4.73
Net debt to EBITDA 0.43 0.37 0.96

Dividend

Metric JUNS SXTP Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric JUNS SXTP Biotechnology median
Market cap 3.80m 4.08m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack